BF2d

General Information


DRACP ID  DRACP00069

Peptide Name   BF2d

Sequence  TRSSRAGLQWPVGRVHRLLRKGGC

Sequence Length  24

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Transducing peptide Cell-penetrating peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma 80-90% viablity=100 µM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00069

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C115H196N44O29S

Absent amino acids  DEFIMNY

Common amino acids  R

Mass  310158

Pl  12.68

Basic residues  7

Acidic residues  0

Hydrophobic residues  7

Net charge  7

Boman Index  -6770

Hydrophobicity  -64.17

Aliphatic Index  77.08

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  239.13

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 12417587

Title  Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes

Doi 10.1074/jbc.M208762200

Year  2003

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.